Signaling Pathways
-
A5793 Quizartinib (AC220)Target: FLT3Summary: FLT3 inhibitor,potent and selective
-
A5801 BIX 02189Target: MEK|ERKSummary: Selective MEK5 inhibitor
-
A8214 AZD80552 CitationTarget: mTORSummary: MTOR inhibitor
-
A5919 AZD7762Target: ChkSummary: Checkpoint kinase inhibitor,ATP competitive
-
A5970 IrbesartanTarget: Angiotensin AT1 ReceptorsSummary: Angiotensin II inhibitor
-
A5979 Tie2 kinase inhibitorTarget: Tie-2Summary: Tie-2(Tie2 ) inhibitor
-
A2024 PD168393Target: PDGFR|FGFR|EGFR|PKC|insulinSummary: EGFR inhibitor
-
A2224 Stattic5 CitationTarget: STATSummary: STAT3 inhibitor,small-molecule and potent
-
A2249 T0901317Target: Liver X receptors (LXRs)Summary: Liver X receptor agonist,potent and selective
-
A1947 MEK162 (ARRY-162, ARRY-438162)Target: MEKSummary: MEK1/2 inhibitor,potent and selective